Sandra Cauwenberghs
Investor Relations Contact bij GALAPAGOS NV
Profiel
Sandra Cauwenberghs is currently working as a Senior Director-Investor Relations at Galapagos NV.
Previously, she worked as an Analyst at KBC Securities NV from 2017 to 2020.
She also held the position of Head-Pharmacology at iTeos Therapeutics SA. Dr. Cauwenberghs holds a doctorate degree from Maastricht University and a graduate degree from Katholieke Universiteit Leuven.
Actieve functies van Sandra Cauwenberghs
| Bedrijven | Functie | Begin |
|---|---|---|
| GALAPAGOS NV | Investor Relations Contact | 01-11-2020 |
Eerdere bekende functies van Sandra Cauwenberghs
| Bedrijven | Functie | Einde |
|---|---|---|
KBC Securities NV
 KBC Securities NV Investment Banks/BrokersFinance KBC Securities NV is a broker/dealer firm headquartered in Brussels, Belgium. The firm was founded in 1998 and is a wholly owned subsidiary of KBC Bank NV, itself a subsidiary of KBC Groupe SA (EBR: KBC). KBC Securities provides liquidity and order execution services to institutional clients internationally, from investment banks to mutual funds and private investors. | Analyst-Equity | 01-11-2020 |
iTeos Therapeutics SA
 iTeos Therapeutics SA Pharmaceuticals: MajorHealth Technology iTeos Therapeutics SA engages in the discovery of immunomodulators for cancer therapy. It operates as a biotechnology company which focuses on targeting metabolism of the tumor microenvironment through development of small-molecule immunomodulators for cancer treatment. The firm develops small molecules designed to target the tumor microenvironment by inhibiting cancer-induced immune suppression. Targeting such resistance mechanisms will enhance the clinical efficacy of both standards of care treatments as well as the newer immunomodulatory therapies based on the blockade of immune checkpoints. The company was founded in 2011 by Michel Detheux and Benoit Van den Eynde and is headquartered in Gosselies, Belgium. | Corporate Officer/Principal | - |
Opleiding van Sandra Cauwenberghs
| Maastricht University | Doctorate Degree |
| Katholieke Universiteit Leuven | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| GALAPAGOS NV | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
KBC Securities NV
KBC Securities NV Investment Banks/BrokersFinance KBC Securities NV is a broker/dealer firm headquartered in Brussels, Belgium. The firm was founded in 1998 and is a wholly owned subsidiary of KBC Bank NV, itself a subsidiary of KBC Groupe SA (EBR: KBC). KBC Securities provides liquidity and order execution services to institutional clients internationally, from investment banks to mutual funds and private investors. | Finance |
iTeos Therapeutics SA
iTeos Therapeutics SA Pharmaceuticals: MajorHealth Technology iTeos Therapeutics SA engages in the discovery of immunomodulators for cancer therapy. It operates as a biotechnology company which focuses on targeting metabolism of the tumor microenvironment through development of small-molecule immunomodulators for cancer treatment. The firm develops small molecules designed to target the tumor microenvironment by inhibiting cancer-induced immune suppression. Targeting such resistance mechanisms will enhance the clinical efficacy of both standards of care treatments as well as the newer immunomodulatory therapies based on the blockade of immune checkpoints. The company was founded in 2011 by Michel Detheux and Benoit Van den Eynde and is headquartered in Gosselies, Belgium. | Health Technology |
